Company Overview and News

9
Not even a strong earnings season will break stocks out of their range, Morgan Stanley says - MarketWatch

7h marketwatch
The second-quarter earnings season just started in the U.S., and while the initial reads have shown strong growth for both profits and revenue, such results may not be enough to power the market out of the range it has been stuck in for months.
WFCNP C.WSA MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA WFC.PRT C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS C C.PRL C.PRJ C.PRK C.PRG C.PRC MS.PRI C.PRPCL MS.PRK CGBBW

13
U.S. banks depositors shifting money, asking for higher rates

11h reuters
NEW YORK, July 16 (Reuters) - Slowly but surely, depositors are starting to shift money from basic U.S. bank accounts to products that pay more than a sliver of a percent in interest.
WFCNP C.WSA WFC.PRL WFC.PRJ WFC.PRT C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS C C.PRL PNC.PRP C.PRJ PNC.PRQ C.PRK PNCFO C.PRG C.PRC PNC.WS C.PRPCL CGBBW PNC PNUCL

5
Bank of America profit up on consumer loan growth, lower expenses

18h channelnewsasia
NEW YORK: Bank of America Corp reported quarterly profit above expectations as the second-largest US lender cut expenses and benefited from growth in loans and deposits on the back of a strengthening economy.
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

58
Stock Market News For Jul 16, 2017

19h zacks
Markets closed higher on Friday, with the S&P 500 posting its highest close in more than five months. The Dow too reclaimed its 25,000 mark for the first time in almost a month. The rally was led by tech and industrial stocks, which offset a decline in financial stocks, as results from three of the major banks failed to boost investors’ confidence.
WFCNP FB MTSI C.WSA CAT WBA WFC.PRL WFC.PRJ WFC.PRT C.WS.B WFC.PRR WFC.PRQ AMZN WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS C CATR C.PRL C.PRJ C.PRK UTX C.PRG C.PRC GTT C.PRPCL CGBBW MSFT

5
BofA profit beats on consumer loan growth, lower expenses

19h theedgemarkets
NEW YORK (July 16): Bank of America Corp reported quarterly profit above expectations as the second-largest US lender cut expenses and benefited from growth in loans and deposits on the back of a strengthening economy.
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

5
BofA profit beats on consumer loan growth, lower expenses - Channel NewsAsia

20h channelnewsasia
Bank of America Corp reported a 36.3 percent jump in quarterly profit, helped by loan growth across its businesses, lower expenses and a smaller tax bill.
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

5
BofA profit beats on consumer loan growth, lower expenses

20h reuters
(Reuters) - Bank of America Corp reported quarterly profit above expectations as the second-largest U.S. lender cut expenses and benefited from growth in loans and deposits on the back of a strengthening economy.
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

5
MOVES-First Abu Dhabi Bank appoints UAE investment banking head

23h reuters
July 16 (Reuters) - First Abu Dhabi Bank said it had appointed Mohanad Al-Borno as head of corporate and investment banking for the United Arab Emirates.
C.WSA C C.PRL C.PRJ C.PRK C.PRG C.PRC C.WS.B C.PRPCL CGBBW C.WS.A C.PRP C.PRU C.PRS

5
Top-grade iron ore may spike to $100

2018-07-16 bworldonline
High-grade iron ore may spike to $100 a metric ton as China intensifies a clampdown on pollution by restraining industrial activity, adding further momentum to a trend that’s reshaped the global market in recent years and driven buyers in Asia’s top economy seek out better-quality material.
C.WSA BLT C C.PRL VALE3 C.PRJ BHPBF C.PRK C.PRG C.PRC FSUGY C.WS.B FSUMF BHP C.PRPCL CGBBW C.WS.A C.PRP BBL BHP C.PRU FMG BHPLF C.PRS

15
SP 500 at five-month high, but banks weigh after results

2018-07-14 moneycontrol
US stocks rose slightly on Friday, putting the S&P 500 at its highest closing level in more than five months, as gains in industrials and other areas offset a drop in financials after results from three of the big banks mostly disappointed.
WFCNP MTSI C.WSA DB CAT TWX WFC.PRL NFLX WFC.PRJ WFC.PRT C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN BOE C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS CATR C C.PRL C.PRJ C.PRK C.PRG TWC C.PRC C.PRPCL CGBBW BA

9
Citigroup executives see better growth ahead, but not yet

2018-07-14 malaymail
NEW YORK, July 14 — Citigroup Inc is still on track to hit its goals for efficiency and revenue growth, executives said yesterday, as analysts pressed them to explain how those expectations line up with second-quarter results.
WFCNP C.WSA WFC.PRL WFC.PRJ WFC.PRT C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS C C.PRL C.PRJ C.PRK C.PRG C.PRC C.PRPCL CGBBW

14
S&P 500 at five-month high, but banks weigh after results

2018-07-14 malaymail
NEW YORK, July 14 — US stocks rose slightly yesterday, putting the S&P 500 at its highest closing level in more than five months, as gains in industrials and other areas offset a drop in financials after results from three of the big banks mostly disappointed.
WFCNP MTSI C.WSA DB CAT TWX WFC.PRL NFLX WFC.PRJ WFC.PRT C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN BOE C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS CATR C C.PRL C.PRJ C.PRK C.PRG TWC C.PRC C.PRPCL CGBBW TRI BA

11
Bankers Quit Goldman, Citigroup for Biotech Riches in Hong Kong - Bloomberg

2018-07-14 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
C.WSA DB GS.PRB GS.PRA GS C.WS.B GLSSP C.WS.A C.PRP JEF RWA C.PRU C.PRS JBK C C.PRL GSC GS.PRICL C.PRJ TFG C.PRK C.PRG GSJ C.PRC GS.PRJ GS.PRI C.PRPCL GS.PRD CGBBW LAZ GS.PRC GJS GS.PRN GS.PRK

10
Eyes Turn to Goldman, Morgan Stanley With Rivals Tapping M&A Windfall - Bloomberg

2018-07-13 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
C.WSA GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA GS C.WS.B GLSSP C.WS.A C.PRP C.PRU MS C.PRS JBK C C.PRL GSC GS.PRICL C.PRJ TFG C.PRK C.PRG GSJ C.PRC GS.PRJ GS.PRI MS.PRI C.PRPCL GS.PRD MS.PRK CGBBW GS.PRC GJS GS.PRN GS.PRK

9
Bank profits grow, lending doesn’t keep pace

2018-07-13 sfgate
Tax cuts, deregulation and a buoyant economy were always expected to drive profits higher at most American banks in the latest quarter.
WFCNP C.WSA WFC.PRL WFC.PRJ WFC.PRT C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS C C.PRL C.PRJ C.PRK NYTAB CPICQ C.PRG C.PRC C.PRPCL CGBBW

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

4h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

6h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 172967317